However, these existing models, including those based on Cox regression [19], or staging systems like BCLC [20,21], often rely on linear assumptions and may overlook critical biomarkers such as HBV-DNA and CA125, thus limiting their predictive power for ER, particularly in subgroups like MVI-negative HCC. Here, MUC16 is linked to hepatocellular carcinoma.